Erratum for BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience. Rihawi K, Giannarelli D, Galetta D, Delmonte A, Giavarra M, Turci D, Garassino M, Tiseo M, Barbieri F, Panni S, Ardizzoni A. J Thorac Oncol. 2019 Mar;14(3):e57-e59. doi: 10.1016/j.jtho.2018.11.036.